- Home
- Publications
- Publication Search
- Publication Details
Title
Breast cancer and its therapeutic targets: A comprehensive review
Authors
Keywords
-
Journal
Chemical Biology & Drug Design
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-11-03
DOI
10.1111/cbdd.14384
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PALVEN: phase 1b trial of palbociclib, letrozole and venetoclax in estrogen receptor- and BCL2-positive advanced breast cancer
- (2022) Christine Muttiah et al. Future Oncology
- Malignant granular cell tumors: Combining cytological and pathological findings for a definitive diagnosis
- (2022) Atsumi Enomoto et al. DIAGNOSTIC CYTOPATHOLOGY
- New and Emerging Targeted Therapies for Advanced Breast Cancer
- (2022) Kristie H. Lau et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implications
- (2022) Umar Mehraj et al. SEMINARS IN CANCER BIOLOGY
- Role of STAT3 in the initiation, progression, proliferation and metastasis of breast cancer and strategies to deliver JAK and STAT3 inhibitors
- (2022) Yirivinti Hayagreeva Dinakar et al. LIFE SCIENCES
- Current and future burden of breast cancer: Global statistics for 2020 and 2040
- (2022) Melina Arnold et al. BREAST
- Syndecan-4 regulates the HER2-positive breast cancer cell proliferation cells via CK19/AKT signalling
- (2022) Son H. Pham et al. BIOCHIMIE
- CDK4/6 Inhibitor Treatments in Patients with Hormone Receptor Positive, Her2 Negative Advanced Breast Cancer: Potential Molecular Mechanisms, Clinical Implications and Future Perspectives
- (2021) Michela Roberto et al. Cancers
- γ-Secretase inhibitors for breast cancer and hepatocellular carcinoma: From mechanism to treatment
- (2021) Hui Jia et al. LIFE SCIENCES
- Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
- (2021) Wei Cao et al. CHINESE MEDICAL JOURNAL
- Hedgehog signaling mechanism and role in cancer
- (2021) Jin Jiang SEMINARS IN CANCER BIOLOGY
- CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
- (2021) Navid Sobhani et al. Cancers
- Evaluation of knowledge, awareness and attitudes towards breast cancer risk factors and early detection among females in Bangladesh: A hospital based cross-sectional study
- (2021) Nur E. Alam et al. PLoS One
- Prognostic impact of radiation therapy in tubular carcinoma of the breast
- (2021) Jessica Stauber et al. RADIOTHERAPY AND ONCOLOGY
- Grading of invasive breast carcinoma: the way forward
- (2021) C. van Dooijeweert et al. VIRCHOWS ARCHIV
- Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
- (2021) Carla L. Alves et al. Nature Communications
- PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
- (2021) Jinhua Liu et al. Frontiers in Pharmacology
- Recent Advances in Enhancing the Therapeutic Index of PARP Inhibitors in Breast Cancer
- (2021) Camille Franchet et al. Cancers
- Clinicopathological analysis of invasive cribriform carcinoma of the breast, with review of the literature
- (2021) Sinem Demir et al. Annals of Diagnostic Pathology
- A review on epidermal growth factor receptor's role in breast and non-small cell lung cancer
- (2021) Vetriselvan Subramaniyan et al. CHEMICO-BIOLOGICAL INTERACTIONS
- An Update on the Molecular and Clinical Characteristics of Apocrine Carcinoma of the Breast
- (2021) Semir Vranic et al. Clinical Breast Cancer
- Wnt/beta-catenin and PI3K/Akt/mtor Signaling Pathways in Glioblastoma: Two main targets for drug design: A Review
- (2020) Seyed Hossein Shahcheraghi et al. CURRENT PHARMACEUTICAL DESIGN
- The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer
- (2020) Lei Ding et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer
- (2020) Masanori Oshi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial☆
- (2020) F. Montemurro et al. ANNALS OF ONCOLOGY
- Notch receptors and ligands in inflammatory arthritis – a systematic review
- (2020) Alan Šućur et al. IMMUNOLOGY LETTERS
- Invasive apocrine carcinoma of the breast: clinicopathologic features and comprehensive genomic profiling of 18 pure triple-negative apocrine carcinomas
- (2020) Xiangjie Sun et al. MODERN PATHOLOGY
- Histopathological Classification of Breast Cancer Images Using a Multi-Scale Input and Multi-Feature Network
- (2020) Taimoor Shakeel Sheikh et al. Cancers
- Homologous recombination deficiency real-time clinical assays, ready or not?
- (2020) Katherine Fuh et al. GYNECOLOGIC ONCOLOGY
- Poly(ADP-ribose) polymerase inhibition: past, present and future
- (2020) Nicola J. Curtin et al. NATURE REVIEWS DRUG DISCOVERY
- Altered G1 signaling order and commitment point in cells proliferating without CDK4/6 activity
- (2020) Chad Liu et al. Nature Communications
- Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability
- (2020) Sarah A. Jeffreys et al. Cells
- Immunotherapy for early breast cancer: too soon, too superficial, or just right?
- (2020) M.A. Franzoi et al. ANNALS OF ONCOLOGY
- STAT3 and its targeting inhibitors in osteosarcoma
- (2020) Yun Liu et al. CELL PROLIFERATION
- Targeting the Wnt/β-catenin signaling pathway in cancer
- (2020) Ya Zhang et al. Journal of Hematology & Oncology
- Safety and Tolerability of Phosphatidylinositol-3-Kinase (PI3K) Inhibitors in Oncology
- (2019) Giuseppe Curigliano et al. DRUG SAFETY
- Micropapillary Variant of Mucinous Carcinomas of the Breast Display Genetic Alterations Intermediate Between Mucinous Carcinomas and Micropapillary Carcinomas
- (2019) Fresia Pareja et al. HISTOPATHOLOGY
- Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer
- (2019) Fabrice André et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of HER2-Positive Breast Cancer Growth by Blocking the HER2 Signaling Pathway with HER2-Glycan-Imprinted Nanoparticles
- (2019) Yueru Dong et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Invasive lobular breast cancer: A review of pathogenesis, diagnosis, management, and future directions of early stage disease
- (2019) Mathew Thomas et al. SEMINARS IN ONCOLOGY
- Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
- (2019) Park et al. Cancers
- Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype
- (2019) M. V. Giuli et al. Journal of Oncology
- Selective progesterone receptor modulators in early stage breast cancer: a randomized, placebo-controlled Phase II window of opportunity trial using telapristone acetate.
- (2019) Oukseub Lee et al. CLINICAL CANCER RESEARCH
- Estrogen signaling: An emanating therapeutic target for breast cancer treatment
- (2019) Tanmay Saha et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting AKT for cancer therapy
- (2019) Maryam Shariati et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Heterogeneity of breast cancer: The importance of interaction between different tumor cell populations
- (2019) Indrė Januškevičienė et al. LIFE SCIENCES
- PI3K Inhibitors in Breast Cancer Therapy
- (2019) Haley Ellis et al. Current Oncology Reports
- Biomarker-targeted fluorescent probes for breast cancer imaging
- (2018) Dongfang Yue et al. CHINESE CHEMICAL LETTERS
- Advances in the systemic treatment of triple-negative breast cancer
- (2018) J.M. Lebert et al. Current Oncology
- Dual or multi-targeting inhibitors: The next generation anticancer agents
- (2018) Nulgumnalli Manjunathaiah Raghavendra et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Molecular targeted therapy: treating cancer with specificity
- (2018) Yeuan Ting Lee et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges
- (2018) Ramesh Butti et al. Molecular Cancer
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- The STAT3 Target Gene TNFRSF1A Modulates the NF-κB Pathway in Breast Cancer Cells
- (2018) Susana P. Egusquiaguirre et al. NEOPLASIA
- MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling
- (2018) Hui Quan et al. BIOMEDICINE & PHARMACOTHERAPY
- Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review
- (2018) Kamal Pandey et al. INTERNATIONAL JOURNAL OF CANCER
- Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
- (2018) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunoprofile of metaplastic carcinomas of the breast
- (2017) Emad A Rakha et al. HISTOPATHOLOGY
- Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast
- (2017) Marion Lavigne et al. MODERN PATHOLOGY
- Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response–Targeted Therapies in Breast Cancer
- (2017) Kalnisha Naidoo et al. MOLECULAR CANCER THERAPEUTICS
- Combined immune checkpoint blockade as a therapeutic strategy for BRCA1 -mutated breast cancer
- (2017) Emma Nolan et al. Science Translational Medicine
- The roles of signal transducer and activator of transcription factor 3 in tumor angiogenesis
- (2017) Peng Gao et al. Oncotarget
- Intrinsic molecular subtypes of HER2+ breast cancer
- (2017) Aleix Prat et al. Oncotarget
- MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study
- (2017) Kirsi Holli-Helenius et al. BMC MEDICAL IMAGING
- Overall survival and progression-free survival with endocrine therapy for hormone receptor-positive, HER2-negative advanced breast cancer: review
- (2017) Tomás Reinert et al. Therapeutic Advances in Medical Oncology
- CXCR4-SDF-1 interaction potentially mediates trafficking of circulating tumor cells in primary breast cancer
- (2016) M. Mego et al. BMC CANCER
- The prognostic significance of human epidermal growth factor receptor family protein expression in operable pancreatic cancer
- (2016) Qin Li et al. BMC CANCER
- Clinical Development of the CDK4/6 Inhibitors Ribociclib and Abemaciclib in Breast Cancer
- (2016) Romualdo Barroso-Sousa et al. Breast Care
- Pure and Mixed Mucinous Carcinoma of the Breast: A Comparison of Clinical Outcomes and Treatment Results
- (2016) Piotr Skotnicki et al. Breast Journal
- Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors
- (2016) Shom Goel et al. CANCER CELL
- Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) –Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline
- (2016) Neelima Denduluri et al. JOURNAL OF CLINICAL ONCOLOGY
- Atypical medullary carcinoma of the breast has similar prognostic factors and survival to typical medullary breast carcinoma: 3,976 cases from the National Cancer Data Base
- (2016) Alina M. Mateo et al. JOURNAL OF SURGICAL ONCOLOGY
- Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
- (2016) Valsamo Anagnostou et al. Cancer Discovery
- Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression
- (2016) Daniela Rovito et al. Oncotarget
- Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors
- (2016) Tadas Rimkus et al. Cancers
- Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
- (2016) Brian D. Lehmann et al. PLoS One
- Constitutive activation of STAT3 in breast cancer cells: A review
- (2015) Kasturi Banerjee et al. INTERNATIONAL JOURNAL OF CANCER
- Neuroendocrine Carcinoma of the Breast: Current Evidence and Future Perspectives
- (2015) A. Inno et al. ONCOLOGIST
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More